Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/biotech/bayers-asundexian-cuts-stroke-risk-phase-3-reviving-hopes-fxia-class" hreflang="en">Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class</a>
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has s...
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page